549 related articles for article (PubMed ID: 8752609)
1. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
2. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
Phemister DA; Laurent S; Harrison FN
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel implant use among adolescents.
Mashburn M
J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
[TBL] [Abstract][Full Text] [Related]
5. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
Brache V; Alvarez F; Faundes A; Cochon L; Thevenin F
Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
[TBL] [Abstract][Full Text] [Related]
6. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
7. A preliminary report of Norplant implant insertions in a large urban family planning program.
Crosby UD; Schwarz BE; Gluck KL; Heartwell SF
Contraception; 1993 Oct; 48(4):359-66. PubMed ID: 8222663
[TBL] [Abstract][Full Text] [Related]
8. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
9. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
10. The timing of norplant insertion and postpartum depression in teenagers.
Stevens-Simon C; Kelly L; Wallis J
J Adolesc Health; 2000 Jun; 26(6):408-13. PubMed ID: 10822182
[TBL] [Abstract][Full Text] [Related]
11. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
12. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
13. Assessing the acceptability of Norplant contraceptive in four patient populations.
Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
[TBL] [Abstract][Full Text] [Related]
14. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
15. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
[TBL] [Abstract][Full Text] [Related]
16. Subdermal contraceptive implants in nurse-midwifery practice.
Emerling JM; Paluzzi P; Leiva J; Cullins VE
J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
[TBL] [Abstract][Full Text] [Related]
17. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with Norplant in an inner city population.
Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
[TBL] [Abstract][Full Text] [Related]
19. New concepts in contraception: Norplant subdermal implant.
Lynn MM; Holdcroft C
Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
[TBL] [Abstract][Full Text] [Related]
20. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]